Insider Sale: Chief Scientific Officer Steven Bellon Sells 20,000 Shares of...

Published on 21 Sep 2024 on GuruFocus.com · via Yahoo Finance

On September 9, 2024, Steven Bellon, Chief Scientific Officer of Foghorn Therapeutics Inc...

Read the rest of the article

Start tracking your investments with Statfolio

On September 9, 2024, Steven Bellon, Chief Scientific Officer of Foghorn Therapeutics Inc...

GuruFocus.com · via Yahoo Finance 21 Sep 2024

Last week, you might have seen that Foghorn Therapeutics Inc. (NASDAQ:FHTX) released its quarterl...

Simply Wall St. via Yahoo Finance 12 May 2024

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.59 per share versus the Zac...

Zacks via Yahoo Finance 6 May 2024

Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $6.54, gaining 5.1% over the ...

Zacks via Yahoo Finance 13 Mar 2024

Investors might want to bet on Foghorn Therapeutics Inc. (FHTX), as it has been recently upgraded...

Zacks via Yahoo Finance 13 Mar 2024

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.57 per share versus the Zac...

Zacks via Yahoo Finance 7 Mar 2024

Foghorn Therapeutics Inc. (FHTX) shares ended the last trading session 22.7% higher at $5.95. The...

Zacks via Yahoo Finance 12 Feb 2024

Key Insights Significantly high institutional ownership implies Foghorn Therapeutics' stock price...

Simply Wall St. via Yahoo Finance 23 Jan 2024

Investors might want to bet on Foghorn Therapeutics Inc. (FHTX), as it has been recently upgraded...

Zacks via Yahoo Finance 26 Dec 2023

Those holding Foghorn Therapeutics Inc. (NASDAQ:FHTX) shares would be relieved that the share pri...

Simply Wall St. via Yahoo Finance 1 Dec 2023